# Oruka Therapeutics, Inc.: Form SC 13D, filed Sep 6, 2024

- Company: [Oruka Therapeutics, Inc.](/companies/orka.md) (CIK 907654)
- Form: SC 13D
- Filed: 2024-09-06
- Accepted by EDGAR: Sep 6, 2024, 17:08 ET
- Period: not reported
- Accession: 0001213900-24-076599
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/907654/000121390024076599/ea0213742-13dfair_oruka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/907654/000121390024076599/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/907654/000121390024076599/ea0213742-13dfair_oruka.htm

Filed Sep 6, 2024.
Source: SEC EDGAR, the filing index for accession 0001213900-24-076599. Last ingested by Listed: Nov 2, 2026, 20:24 ET. No prices; not investment advice.